FINWIRES · TerminalLIVE
FINWIRES

Market Chatter: BlackRock Eyes 15% Stake in Go Ahead of Taxi App's June 16 Listing

By

BlackRock plans to acquire a 15.2% stake in Japanese taxi app Go for roughly 28 billion yen as part of the company's upcoming initial public offering, Nikkei Asia reported Tuesday.

The purchase amounts to 11.81 million shares, the report said.

Go detailed its secondary offering in a Monday statement, announcing plans to sell up to 36.9 million shares at an indicative price range of 2,350 to 2,400 yen per share, plus an overallotment option of up to 3.55 million shares managed by Nomura Securities.

Major existing shareholders selling down their stakes include DeNA(TYO:2432), NTT DOCOMO, and Toyota (TYO:7203), along with domestic sellers such as Aioi Nissin Dowa Insurance, SMBC Trust Bank, KDDI (TYO:9433), and Dentsu Group (TYO:4324).

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Related Articles

Asia

Zeotech Trial Shows ZeoteCH4 Technology Reduced Methane Emissions by Average of 92%

Zeotech's (ASX:ZEO) methane control program results showed that the company's zeoteCH4 technology reduced methane emissions by an average of 92% compared with untreated control areas over the initial monitoring period, according to a Tuesday filing with the Australian bourse.Griffith University is undertaking the on-site trial at the North Burnett Regional Council landfill in Queensland, confirming that the program is progressing as planned, with early results "exceeding" expectations, the filing said.The first monitoring period spans from March 18 to April 30, with monitoring continuing until early August, per the filing.

$ASX:ZEO
Asia

Simcere Pharma Wins Promotion Rights for PrimeGenX's Atopic Dermatitis Drug

Simcere Pharmaceutical (HKG:2096) entered into an exclusive promotion service agreement with PrimeGenX Therapeutics for Pumecitinib Gel, a Monday Hong Kong bourse filing said.Under the agreement, Simcere obtained exclusive promotion rights for the drug's dermatology indications in mainland China, Hong Kong, and Macau.Pumecitinib Gel is described as the "world's first" JAK inhibitor gel for atopic dermatitis and is also being developed for additional dermatology indications, including atopic dermatitis in children aged 2 to 11, prurigo nodularis, and non-segmental vitiligo, according to the filing.

$HKG:2096
Asia

Lachlan Star Says Western Australia Gold Project Drilling Extends Mineralization, Shares Fall 3%

Lachlan Star (ASX:LSA) extended mineralization at the New Waverley gold project in Western Australia via a maiden 13-hole 1,031-meter diamond drilling program, according to a Tuesday Australian bourse filing.It encountered intercepts of 7.6 meters at 2.65 grams-per-tonne grade of gold from 18.5 meters, as well as 1.6 meters at 9.83 g/t grade of gold from 44.5 meters.A follow-up reverse circulation drilling program of around 2,400 meters will begin within the month, designed to infill and extend known mineralization.Its shares fell 3% in recent trading on Tuesday.

$ASX:LSA